Xconomy’s Digital Events →
Tasso, a Seattle-based startup, plans to begin selling its flagship device by June. It’s designed to stick to a patient’s upper arm and collect a blood sample in about two minutes. Image courtesy of Tasso.
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.